Full name
INSTYTUT FARMACJI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
INSTYTUT FARMACJI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. WIDNOKRĄG 8, 30-685 KRAKÓW
TAX ID6793075756
Rate company:
INSTYTUT FARMACJI SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID6793075756
KRS0000397825
Share capital5,100.00 zł
address
UL. WIDNOKRĄG 8, 30-685 KRAKÓW
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
6793075756
REGON
122444633
KRS
0000397825
Legal form
limited liability company
Register Address
UL. WIDNOKRĄG 8, 30-685 KRAKÓW
Date of registration in KRS
2011-10-04
Date of commencement of economic activity
2011-10-04
Act signature
KR.XI NS-REJ.KRS/8623/25/36
Pkd codes
70.20.Z - Business and management consultancy activities
58.11.Z - Publishing of books
58.12.Z - Publishing of newspapers
58.13.Z - Publishing of journals and periodicals
58.29.Z - Publishing of other software
62.10.B - Programming activities
73.20.Z - Market research and public opinion polling
82.99.B - Other business support activities, not elsewhere classified
Payer VAT status
Active
Vat list bank account(s)
PL14 1090 2053 0000 0001 1763 6033 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
K PLN | K PLN | K PLN | % | |
Gross profit (loss)  | 20,6 | -6,7 | -7,1 | -6,4 |
EBITDA | 20,8 | -6,7 | -7,1 | -6,4 |
Short time liabilities | 15,8 | 13,8 | 13,9 | 0,8 |
Equity capital | 32,1 | 25,4 | 18,3 | -28 |
Operating profit (EBIT) | 20,8 | -6,7 | -7,1 | -6,4 |
Assets | 47,9 | 39,2 | 32,2 | -17,9 |
Net profit (loss) | 20,6 | -6,7 | -7,1 | -6,4 |
Cash | 16 | 8,9 | 0,5 | -94,8 |
Net income from sale | 32 | 1,3 | 0 | -100 |
Liabilities and provisions for liabilities | 15,8 | 13,8 | 13,9 | 0,8 |
Working assets | 46,9 | 38,2 | 31,2 | -18,4 |
Depreciation | 0 | 0 | 0 | 0 |
% | % | % | p.p. | |
Profitability of capital | 64,3 | -26,4 | -39 | -12,6 |
Equity capital to total assets | 67 | 64,8 | 56,8 | -8 |
Gross profit margin | 64,5 | -513,1 | -577,6 | |
EBITDA Margin | 64,9 | -513,1 | -578 | |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 180 | 3865 | 2 147 483 648 | 2 147 479 783 |
Current financial liquidity indicator | 2.963886260986328 | 2.7659218311309814 | 2.241025686264038 | -0,6 |
Net dept to EBITDA | -0.77176433801651 | 1.336066484451294 | 0.06575211137533188 | -1,2 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.
Companies registered in the same sector
M&S PARTNER
Wydminy
Dot24.Eu sp. z o.o.
Kraków
Qualitas Grupa Doradcza sp. z o.o.
Dąbrówki
Zaufany Ekspert Finansowy
Gdańsk
Centrum Kreowania Liderów S.A.
Katowice
Set on Target
Świętochłowice
Candle World
Gorzów Wielkopolski
FirmU Consulting Tomasz Nowiński
WROCŁAW
Tomasz Sikora & Partnerzy
Słupsk